160 related articles for article (PubMed ID: 37526864)
1. Knockdown of Notch Suppresses Epithelial-mesenchymal Transition and Induces Angiogenesis in Oral Submucous Fibrosis by Regulating TGF-β1.
Wang J; Yang L; Mei J; Li Z; Huang Y; Sun H; Zheng K; Kuang H; Luo W
Biochem Genet; 2024 Apr; 62(2):1055-1069. PubMed ID: 37526864
[TBL] [Abstract][Full Text] [Related]
2. Arecoline-induced myofibroblast transdifferentiation from human buccal mucosal fibroblasts is mediated by ZEB1.
Chang YC; Tsai CH; Lai YL; Yu CC; Chi WY; Li JJ; Chang WW
J Cell Mol Med; 2014 Apr; 18(4):698-708. PubMed ID: 24400868
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of miR-497 Attenuates Oral Submucous Fibrosis by Inhibiting Myofibroblast Transdifferentiation in Buccal Mucosal Fibroblasts.
Huang J; Zhang H; Fan X; Guo J
Oral Health Prev Dent; 2022 Jun; 20(1):339-348. PubMed ID: 35920886
[TBL] [Abstract][Full Text] [Related]
4. Role of the arecoline/YAP1/BMP4 pathway in promoting endothelial-mesenchymal transition in oral submucous fibrosis.
Yao M; Li J; Yuan S; Zhu X; Hu Z; Li Q; Cao R; Wang W; Fang C
J Oral Pathol Med; 2020 Apr; 49(4):305-310. PubMed ID: 31397922
[TBL] [Abstract][Full Text] [Related]
5. miR-200b ameliorates myofibroblast transdifferentiation in precancerous oral submucous fibrosis through targeting ZEB2.
Liao YW; Yu CC; Hsieh PL; Chang YC
J Cell Mol Med; 2018 Sep; 22(9):4130-4138. PubMed ID: 29893466
[TBL] [Abstract][Full Text] [Related]
6. Arecoline enhances miR-21 to promote buccal mucosal fibroblasts activation.
Yang HW; Yu CC; Hsieh PL; Liao YW; Chu PM; Yu CH; Fang CY
J Formos Med Assoc; 2021 Apr; 120(4):1108-1113. PubMed ID: 33191095
[TBL] [Abstract][Full Text] [Related]
7. Slug mediates myofibroblastic differentiation to promote fibrogenesis in buccal mucosa.
Fang CY; Hsia SM; Hsieh PL; Liao YW; Peng CY; Wu CZ; Lin KC; Tsai LL; Yu CC
J Cell Physiol; 2019 May; 234(5):6721-6730. PubMed ID: 30230545
[TBL] [Abstract][Full Text] [Related]
8. Elevation of S100A4 expression in buccal mucosal fibroblasts by arecoline: involvement in the pathogenesis of oral submucous fibrosis.
Yu CC; Tsai CH; Hsu HI; Chang YC
PLoS One; 2013; 8(1):e55122. PubMed ID: 23383075
[TBL] [Abstract][Full Text] [Related]
9. Raised keratinocyte growth factor-1 expression in oral submucous fibrosis in vivo and upregulated by arecoline in human buccal mucosal fibroblasts in vitro.
Tsai CH; Yang SF; Chen YJ; Chou MY; Chang YC
J Oral Pathol Med; 2005 Feb; 34(2):100-5. PubMed ID: 15641989
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of HIF1A-AS1 impedes the arecoline-induced migration activity of human oral mucosal fibroblasts.
Wang YK; Liu CM; Lin T; Fang CY; Yu CC; Yu CH
J Formos Med Assoc; 2020 Apr; 119(4):879-883. PubMed ID: 31959495
[TBL] [Abstract][Full Text] [Related]
11. miR-10b regulated by Twist maintains myofibroblasts activities in oral submucous fibrosis.
Fang CY; Yu CC; Liao YW; Hsieh PL; Ohiro Y; Chu PM; Huang YC; Yu CH; Tsai LL
J Formos Med Assoc; 2020 Jul; 119(7):1167-1173. PubMed ID: 32265096
[TBL] [Abstract][Full Text] [Related]
12. LINC00084/miR-204/ZEB1 Axis Mediates Myofibroblastic Differentiation Activity in Fibrotic Buccal Mucosa Fibroblasts: Therapeutic Target for Oral Submucous Fibrosis.
Lee YH; Liao YW; Lu MY; Hsieh PL; Yu CC
J Pers Med; 2021 Jul; 11(8):. PubMed ID: 34442351
[TBL] [Abstract][Full Text] [Related]
13. Arctigenin Reduces Myofibroblast Activities in Oral Submucous Fibrosis by LINC00974 Inhibition.
Lin CY; Hsieh PL; Liao YW; Peng CY; Yu CC; Lu MY
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30884781
[TBL] [Abstract][Full Text] [Related]
14. miR-200c inhibits the arecoline-associated myofibroblastic transdifferentiation in buccal mucosal fibroblasts.
Lu MY; Yu CC; Chen PY; Hsieh PL; Peng CY; Liao YW; Yu CH; Lin KH
J Formos Med Assoc; 2018 Sep; 117(9):791-797. PubMed ID: 29958727
[TBL] [Abstract][Full Text] [Related]
15. miR-203 inhibits arecoline-induced epithelial-mesenchymal transition by regulating secreted frizzled-related protein 4 and transmembrane-4 L six family member 1 in oral submucous fibrosis.
Zheng L; Jian X; Guo F; Li N; Jiang C; Yin P; Min AJ; Huang L
Oncol Rep; 2015 Jun; 33(6):2753-60. PubMed ID: 25872484
[TBL] [Abstract][Full Text] [Related]
16. Elevation of Twist expression by arecoline contributes to the pathogenesis of oral submucous fibrosis.
Lee YH; Yang LC; Hu FW; Peng CY; Yu CH; Yu CC
J Formos Med Assoc; 2016 May; 115(5):311-7. PubMed ID: 26088962
[TBL] [Abstract][Full Text] [Related]
17. Epigallocatechin-3-gallate inhibits transforming-growth-factor-β1-induced collagen synthesis by suppressing early growth response-1 in human buccal mucosal fibroblasts.
Hsieh YP; Chen HM; Lin HY; Yang H; Chang JZ
J Formos Med Assoc; 2017 Feb; 116(2):107-113. PubMed ID: 26922429
[TBL] [Abstract][Full Text] [Related]
18. Silencing periostin inhibits myofibroblast transdifferentiation of fibrotic buccal mucosal fibroblasts.
Su JY; Yu CC; Peng CY; Liao YW; Hsieh PL; Yang LC; Yu CH; Chou MY
J Formos Med Assoc; 2021 Nov; 120(11):2010-2015. PubMed ID: 33965260
[TBL] [Abstract][Full Text] [Related]
19. Experimental study on TGF-β1-mediated CD147 expression in oral submucous fibrosis.
Wang W; Xiong H; Hu Z; Zhao R; Hu Y; Chen W; Han Y; Yang L; Hu X; Wang C; Mao T; Xia K; Su T
Oral Dis; 2018 Sep; 24(6):993-1000. PubMed ID: 29457855
[TBL] [Abstract][Full Text] [Related]
20. Paeonol inhibits profibrotic signaling and HOTAIR expression in fibrotic buccal mucosal fibroblasts.
Ho DC; Chen SH; Fang CY; Hsieh CW; Hsieh PL; Liao YW; Yu CC; Tsai LL
J Formos Med Assoc; 2022 May; 121(5):930-935. PubMed ID: 34696937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]